As of 2025-04-18, the Relative Valuation of Adicet Bio Inc (ACET) is (33.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.57 USD, the upside of Adicet Bio Inc based on Relative Valuation is -6001.6%.
The range of the Relative Valuation is (26.12) - (39.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 32.5x | 25.4x |
| Forward P/E multiples | 16.4x - 27.4x | 21.9x |
| Fair Price | (26.12) - (39.09) | (33.72) |
| Upside | -4671.5% - -6942.3% | -6001.6% |
| Date | P/E |
| 2025-04-11 | -0.38 |
| 2025-04-10 | -0.31 |
| 2025-04-09 | -0.36 |
| 2025-04-08 | -0.42 |
| 2025-04-07 | -0.43 |
| 2025-04-04 | -0.45 |
| 2025-04-03 | -0.47 |
| 2025-04-02 | -0.51 |
| 2025-04-01 | -0.52 |
| 2025-03-31 | -0.53 |
| 2025-03-28 | -0.58 |
| 2025-03-27 | -0.60 |
| 2025-03-26 | -0.63 |
| 2025-03-25 | -0.62 |
| 2025-03-24 | -0.64 |
| 2025-03-21 | -0.54 |
| 2025-03-20 | -0.54 |
| 2025-03-19 | -0.55 |
| 2025-03-18 | -0.56 |
| 2025-03-17 | -0.55 |
| 2025-03-14 | -0.55 |
| 2025-03-13 | -0.54 |
| 2025-03-12 | -0.56 |
| 2025-03-11 | -0.55 |
| 2025-03-10 | -0.54 |
| 2025-03-07 | -0.56 |
| 2025-03-06 | -0.59 |
| 2025-03-05 | -0.61 |
| 2025-03-04 | -0.61 |
| 2025-03-03 | -0.59 |
| 2025-02-28 | -0.63 |
| 2025-02-27 | -0.60 |
| 2025-02-26 | -0.63 |
| 2025-02-25 | -0.63 |
| 2025-02-24 | -0.65 |
| 2025-02-21 | -0.68 |
| 2025-02-20 | -0.70 |
| 2025-02-19 | -0.71 |
| 2025-02-18 | -0.68 |
| 2025-02-14 | -0.70 |
| 2025-02-13 | -0.63 |
| 2025-02-12 | -0.61 |
| 2025-02-11 | -0.63 |
| 2025-02-10 | -0.63 |
| 2025-02-07 | -0.68 |
| 2025-02-06 | -0.72 |
| 2025-02-05 | -0.71 |
| 2025-02-04 | -0.65 |
| 2025-02-03 | -0.63 |
| 2025-01-31 | -0.62 |